Pharmacokinetic and pharmacodynamic modeling for acute and chronic pain drug assessment

Bibliography

• Jawahar R, Oh U, Yang S, Lapane KL. A systematic review of pharmacological pain management in multiple sclerosis. Drugs 2013;73(15):1711-22
   PubMed Web of Science ®Google Scholar
• Institute of Medicine Report from the Committee on Advancing Pain Research, Care, and Education: relieving Pain in America, A Blueprint for Transforming Prevention, Care, Education and Research. The National Academies Press. 2011. Available from: http://books.nap.edu/openbook.php?record_id=13172&page=1
   Google Scholar
• Young Casey C, Greenberg MA, Nicassio PM, et al. Transition from acute to chronic pain and disability: a model including cognitive, affective, and trauma factors. Pain 2008;134(1-2):69-79
   PubMed Web of Science ®Google Scholar
• Ferrari LF, Bogen O, Levine JD. Nociceptor subpopulations involved in hyperalgesic priming. Neuroscience 2009;165(3):896-901
   PubMed Web of Science ®Google Scholar
• Reichling DB, Levine JD. Critical role of nociceptor plasticity in chronic pain. Trends Neurosci 2009;32(12):611-18
   PubMed Web of Science ®Google Scholar
• Pergolizzi JV Jr, Raffa RB, Taylor R Jr. Treating acute pain in light of the chronification of pain. Pain Manag Nurs 2012
   PubMed Web of Science ®Google Scholar
• Katz J, Seltzer Z. Transition from acute to chronic postsurgical pain: risk factors and protective factors. Expert Rev Neurother 2009;9(5):723-44
   PubMed Web of Science ®Google Scholar
• Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet 2006;367(9522):1618-25
   PubMed Web of Science ®Google Scholar
• Wilder-Smith OH. Chronic pain and surgery: a review of new insights from sensory testing. J Pain Palliat Care Pharmacother 2011;25(2):146-59
   PubMedGoogle Scholar
• Jones AK. The contribution of functional imaging techniques to our understanding of rheumatic pain. Rheum Dis Clin North Am 1999;25(1):123-52
   PubMed Web of Science ®Google Scholar
• Walsh NE, Brooks P, Hazes JM, et al. Standards of care for acute and chronic musculoskeletal pain: the Bone and Joint Decade (2000 – 2010). Arch Phys Med Rehabil 2008;89(9):1830-45
   PubMed Web of Science ®Google Scholar
• Interagency guideline on opioid-dosing for chronic non-cancer pain treatment: an educational aid to improve care and safety with opioid therapy. 2010
   Google Scholar
• Centers for disease control and Prevention (CDC). Vital signs: overdoses of prescription opioid pain relievers—United States, 1999 – 2008. MMWR Morb Mortal Wkly Rep 2011;60(43):1487-92
   PubMedGoogle Scholar
• CDC. Policy impact: prescription painkiller overdoses: what’s the issue? Available from: http://www.cdc.gov/homeandrecreationalsafety/rxbrief/
   Google Scholar
• Dworkin RH, Backonja M, Rowbotham MC, et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol 2003;60(11):1524-34
   PubMed Web of Science ®Google Scholar
• Feng Y, Roy A, Masson E, et al. Exposure-response relationships of the efficacy and safety of ipilimumab in patients with advanced melanoma. Clin Cancer Res 2013;19(14):3977-86
   PubMed Web of Science ®Google Scholar
• Zhang L, Feng Y, List J, et al. Dapagliflozin treatment in patients with different stages of type 2 diabetes mellitus: effects on glycaemic control and body weight. Diabetes Obes Metab 2010;12(6):510-16
   PubMed Web of Science ®Google Scholar
• Leil TA, Feng Y, Zhang L, et al. Quantification of apixaban’s therapeutic utility in prevention of venous thromboembolism: selection of phase III trial dose. Clin Pharmacol Ther 2010;88(3):375-82
   PubMed Web of Science ®Google Scholar
• Wang X, Roy A, Hochhaus A, et al. Differential effects of dosing regimen on the safety and efficacy of dasatinib: retrospective exposure-response analysis of a Phase III study. Clin Pharmacol 2013;5:85-97
   PubMedGoogle Scholar
• Ting N. Dose Finding in Drug Development (Statistics for Biology and Health). Naitee Ting. editor. Statistics for Biology and Health. Springer; 2006;100:248
   Google Scholar
• Lipkovich I, Mallinckrodt C, Faries D. Exploring dose response in flexible dose trials using marginal structural models. In: Proceedings of the American Statistical Association; papers presented at the Joint Statistical Meetings Annual Meeting, American Statistical Association; papers presented at the Joint Statistical Meetings. American Statistical Association; Alexandria, VA: 2006. p. 677-82
   Google Scholar
• Lipkovich I, Adams DH, Mallinckrodt C, et al. Evaluating dose response from flexible dose clinical trials. BMC Psychiatry 2008;8:3-11
   PubMedGoogle Scholar
• Funatogawa I, Funatogawa T. Dose-response relationship from longitudinal data with response-dependent dose modification using likelihood methods. Biom J 2012;54(4):494-506
   PubMed Web of Science ®Google Scholar
• Xu X, Yuan M, Nandy P. Analysis of dose-response in flexible dose titration clinical studies. Pharm Stat 2012;11(4):280-6
   PubMed Web of Science ®Google Scholar
• Management Asoatfocp. Practice guidelines for chronic pain management: an updated report by the American Society of Anesthesiologists Task Force on Chronic Pain Management and the American Society of Regional Anesthesia and Pain Medicine. Anesthesiology 2010;112(4):810-33
   PubMed Web of Science ®Google Scholar
• Portenoy RK. Current pharmacotherapy of chronic pain. J Pain Symptom Manage 2000;19(1 Suppl):S16-20
   PubMed Web of Science ®Google Scholar
• Ramacciotti AS, Soares BG, Atallah AN. Dipyrone for acute primary headaches. Cochrane Database Syst Rev 2007(2):CD004842
   Google Scholar
• Becker DE. Pain management: part 1: managing acute and postoperative dental pain. Anesth Prog 2010;57(2):67-78; quiz 79-80
   PubMedGoogle Scholar
• Van Dyke T, Litkowski LJ, Kiersch TA, et al. Combination oxycodone 5 mg/ibuprofen 400 mg for the treatment of postoperative pain: a double-blind, placebo- and active-controlled parallel-group study. Clin Ther 2004;26(12):2003-14
   PubMed Web of Science ®Google Scholar
• McNicol E, Strassels SA, Goudas L, et al. NSAIDS or paracetamol, alone or combined with opioids, for cancer pain. Cochrane Database Syst Rev 2005(1):CD005180
   Google Scholar
• Robak J, Wieckowski A, Gryglewski R. The effect of 4-acetamidophenol on prostaglandin synthetase activity in bovine and ram seminal vesicle microsomes. Biochem Pharmacol 1978;27(4):393-6
   PubMed Web of Science ®Google Scholar
• Watanabe S, Bruera E. Corticosteroids as adjuvant analgesics. J Pain Symptom Manage 1994;9(7):442-5
   PubMed Web of Science ®Google Scholar
• Goppelt-Struebe M, Wolter D, Resch K. Glucocorticoids inhibit prostaglandin synthesis not only at the level of phospholipase A2 but also at the level of cyclo-oxygenase/PGE isomerase. Br J Pharmacol 1989;98(4):1287-95
   PubMed Web of Science ®Google Scholar
• Oyanagui Y. Physiological regulation of vascular permeability by endogenous glucocorticoids and active oxygen. Inflammation 1983;7(1):81-9
   PubMed Web of Science ®Google Scholar
• Oyanagi Y, Suzuki S. Vasoregulin, a glucocorticoid-inducible vascular permeability inhibitory protein. Agents Actions 1985;17:270-7
   Google Scholar
• Kardash KJ, Sarrazin F, Tessler MJ, Velly AM. Single-dose dexamethasone reduces dynamic pain after total hip arthroplasty. Anesth Analg 2008;106(4):1253-7
   PubMed Web of Science ®Google Scholar
• Mensah-Nyagan AG, Meyer L, Schaeffer V, et al. Evidence for a key role of steroids in the modulation of pain. Psychoneuroendocrinology 2009;34(Suppl 1):S169-77
   Google Scholar
• Dionne RA, Bartoshuk L, Mogil J, Witter J. Individual responder analyses for pain: does one pain scale fit all? Trends Pharmacol Sci 2005;26(3):125-30
   PubMed Web of Science ®Google Scholar
• Clark MR, Cox TS. Refractory chronic pain. Psychiatr Clin North Am 2002;25(1):71-88
   PubMed Web of Science ®Google Scholar
• Benyamin R, Trescot AM, Datta S, et al. Opioid complications and side effects. Pain Physician 2008;11(2 Suppl):S105-20
   PubMed Web of Science ®Google Scholar
• Watkins LR, Maier SF. Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol Rev 2002;82(4):981-1011
   PubMed Web of Science ®Google Scholar
• Curatolo M, Sveticic G. Drug combinations in pain treatment: a review of the published evidence and a method for finding the optimal combination. Best Pract Res Clin Anaesthesiol 2002;16(4):507-19
   PubMedGoogle Scholar
• Abou Hammoud H, Simon N, Urien S, et al. Intravenous morphine titration in immediate postoperative pain management: population kinetic-pharmacodynamic and logistic regression analysis. Pain 2009;144(1-2):139-46
   PubMed Web of Science ®Google Scholar
• Green B, Chandler S, MacDonald G, et al. Quantifying pain relief following administration of a novel formulation of paracetamol (acetaminophen). J Clin Pharmacol 2010;50(12):1406-13
   PubMed Web of Science ®Google Scholar
• Li H, Mandema J, Wada R, et al. Modeling the onset and offset of dental pain relief by ibuprofen. J Clin Pharmacol 2011;52(1):89-101
   PubMed Web of Science ®Google Scholar
• Goldberg ME, Torjman MC, Schwartzman RJ, et al. Enantioselective pharmacokinetics of (R)- and (S)-ketamine after a 5-day infusion in patients with complex regional pain syndrome. Chirality 2010;23(2):138-43
   PubMed Web of Science ®Google Scholar
• Kietzmann D, Bouillon T, Hamm C, et al. Pharmacodynamic modelling of the analgesic effects of piritramide in postoperative patients. Acta Anaesthesiol Scand 1997;41(7):888-94
   PubMed Web of Science ®Google Scholar
• Inturrisi CE, Portenoy RK, Max MB, et al. Pharmacokinetic-pharmacodynamic relationships of methadone infusions in patients with cancer pain. Clin Pharmacol Ther 1990;47(5):565-77
   PubMed Web of Science ®Google Scholar
• Anderson BJ, Holford NH, Woollard GA, et al. Perioperative pharmacodynamics of acetaminophen analgesia in children. Anesthesiology 1999;90(2):411-21
   PubMed Web of Science ®Google Scholar
• Boni J, Korth-Bradley J, McGoldrick K, et al. Pharmacokinetic and pharmacodynamic action of etodolac in patients after oral surgery. J Clin Pharmacol 1999;39(7):729-37
   PubMed Web of Science ®Google Scholar
• Anderson BJ, Woollard GA, Holford NH. Acetaminophen analgesia in children: placebo effect and pain resolution after tonsillectomy. Eur J Clin Pharmacol 2001;57(8):559-69
   PubMed Web of Science ®Google Scholar
• Kshirsagar S, Gear R, Levine J, Verotta D. A mechanistic model for the sex-specific response to nalbuphine and naloxone in postoperative pain. J Pharmacokinet Pharmacodyn 2008;35(1):69-83
   PubMed Web of Science ®Google Scholar
• Mazoit JX, Butscher K, Samii K. Morphine in postoperative patients: pharmacokinetics and pharmacodynamics of metabolites. Anesth Analg 2007;105(1):70-8
   PubMed Web of Science ®Google Scholar
• Mandema JW, Stanski DR. Population pharmacodynamic model for ketorolac analgesia. Clin Pharmacol Ther 1996;60(6):619-35
   PubMed Web of Science ®Google Scholar
• Kowalski KG, Olson S, Remmers AE, Hutmacher MM. Modeling and simulation to support dose selection and clinical development of SC-75416, a selective COX-2 inhibitor for the treatment of acute and chronic pain. Clin Pharmacol Ther 2008;83(6):857-66
   PubMed Web of Science ®Google Scholar
• Byon W, Ouellet D, Chew M, et al. Exposure-response analyses of the effects of pregabalin in patients with fibromyalgia using daily pain scores and patient global impression of change. J Clin Pharmacol 2010;50(7):803-15
   PubMed Web of Science ®Google Scholar
• Dahan A, Olofsen E, Sigtermans M, et al. Population pharmacokinetic-pharmacodynamic modeling of ketamine-induced pain relief of chronic pain. Eur J Pain 2010;15(3):258-67
   PubMed Web of Science ®Google Scholar
• Sigtermans M, Dahan A, Mooren R, et al. S(+)-ketamine effect on experimental pain and cardiac output: a population pharmacokinetic-pharmacodynamic modeling study in healthy volunteers. Anesthesiology 2009;111(4):892-903
   PubMed Web of Science ®Google Scholar
• Skarke C, Darimont J, Schmidt H, et al. Analgesic effects of morphine and morphine-6-glucuronide in a transcutaneous electrical pain model in healthy volunteers. Clin Pharmacol Ther 2003;73(1):107-21
   PubMed Web of Science ®Google Scholar
• Romberg R, Olofsen E, Sarton E, et al. Pharmacodynamic effect of morphine-6-glucuronide versus morphine on hypoxic and hypercapnic breathing in healthy volunteers. Anesthesiology 2003;99(4):788-98
   PubMed Web of Science ®Google Scholar
• Sarton E, Olofsen E, Romberg R, et al. Sex differences in morphine analgesia: an experimental study in healthy volunteers. Anesthesiology 2000;93(5):1245-54; discussion 1246A
   PubMed Web of Science ®Google Scholar
• Dahan A, Romberg R, Teppema L, et al. Simultaneous measurement and integrated analysis of analgesia and respiration after an intravenous morphine infusion. Anesthesiology 2004;101(5):1201-9
   PubMed Web of Science ®Google Scholar
• Murthy BR, Pollack GM, Brouwer KL. Contribution of morphine-6-glucuronide to antinociception following intravenous administration of morphine to healthy volunteers. J Clin Pharmacol 2002;42(5):569-76
   PubMed Web of Science ®Google Scholar
• Cicero TJ, Nock B, Meyer ER. Sex-related differences in morphine’s antinociceptive activity: relationship to serum and brain morphine concentrations. J Pharmacol Exp Ther 1997;282(2):939-44
   PubMed Web of Science ®Google Scholar
• Cicero TJ, Nock B, Meyer ER. Gender-related differences in the antinociceptive properties of morphine. J Pharmacol Exp Ther 1996;279(2):767-73
   PubMed Web of Science ®Google Scholar
• Aubrun F, Salvi N, Coriat P, Riou B. Sex- and age-related differences in morphine requirements for postoperative pain relief. Anesthesiology 2005;103(1):156-60
   PubMed Web of Science ®Google Scholar
• Staahl C, Upton R, Foster DJ, et al. Pharmacokinetic-pharmacodynamic modeling of morphine and oxycodone concentrations and analgesic effect in a multimodal experimental pain model. J Clin Pharmacol 2008;48(5):619-31
   PubMed Web of Science ®Google Scholar
• Thompson SJ, Koszdin K, Bernards CM. Opiate-induced analgesia is increased and prolonged in mice lacking P-glycoprotein. Anesthesiology 2000;92(5):1392-9
   PubMed Web of Science ®Google Scholar
• Yassen A, Olofsen E, Romberg R, et al. Mechanism-based pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine in healthy volunteers. Anesthesiology 2006;104(6):1232-42
   PubMed Web of Science ®Google Scholar
• Koppert W, Ihmsen H, Korber N, et al. Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model. Pain 2005;118(1-2):15-22
   PubMed Web of Science ®Google Scholar
• Filitz J, Ihmsen H, Gunther W, et al. Supra-additive effects of tramadol and acetaminophen in a human pain model. Pain 2008;136(3):262-70
   PubMed Web of Science ®Google Scholar
• Yassen A, Kan J, Olofsen E, et al. Mechanism-based pharmacokinetic-pharmacodynamic modeling of the respiratory-depressant effect of buprenorphine and fentanyl in rats. J Pharmacol Exp Ther 2006;319(2):682-92
   PubMed Web of Science ®Google Scholar
• Olofsen E, Romberg R, Bijl H, et al. Alfentanil and placebo analgesia: no sex differences detected in models of experimental pain. Anesthesiology 2005;103(1):130-9
   PubMed Web of Science ®Google Scholar
• Lotsch J, Angst MS. The mu-opioid agonist remifentanil attenuates hyperalgesia evoked by blunt and punctuated stimuli with different potency: a pharmacological evaluation of the freeze lesion in humans. Pain 2003;102(1-2):151-61
   PubMed Web of Science ®Google Scholar
• Foster D, Upton R, Christrup L, Popper L. Pharmacokinetics and pharmacodynamics of intranasal versus intravenous fentanyl in patients with pain after oral surgery. Ann Pharmacother 2008;42(10):1380-7
   PubMed Web of Science ®Google Scholar
• Baxter AD, Samson B, Penning J, et al. Prevention of epidural morphine-induced respiratory depression with intravenous nalbuphine infusion in post-thoracotomy patients. Can J Anaesth 1989;36(5):503-9
   PubMed Web of Science ®Google Scholar
• Florez J, Delgado G, Armijo JA. Adrenergic and serotonergic mechanisms in morphine-induced respiratory depression. Psychopharmacologia 1972;24(2):258-74
   PubMedGoogle Scholar
• Romagnoli A, Keats AS. Comparative respiratory depression of tillidine and morphine. Clin Pharmacol Ther 1975;17(5):523-8
   PubMed Web of Science ®Google Scholar
• Klepstad P, Kaasa S, Borchgrevink PC. Start of oral morphine to cancer patients: effective serum morphine concentrations and contribution from morphine-6-glucuronide to the analgesia produced by morphine. Eur J Clin Pharmacol 2000;55(10):713-19
   PubMed Web of Science ®Google Scholar
• Faura CC, Moore RA, Horga JF, et al. Morphine and morphine-6-glucuronide plasma concentrations and effect in cancer pain. J Pain Symptom Manage 1996;11(2):95-102
   PubMed Web of Science ®Google Scholar
• Graves DA, Arrigo JM, Foster TS, et al. Relationship between plasma morphine concentrations and pharmacologic effects in postoperative patients using patient-controlled analgesia. Clin Pharm 1985;4(1):41-7
   PubMedGoogle Scholar
• Olofsen E, van Dorp E, Teppema L, et al. Naloxone reversal of morphine- and morphine-6-glucuronide-induced respiratory depression in healthy volunteers: a mechanism-based pharmacokinetic-pharmacodynamic modeling study. Anesthesiology 2010;112(6):1417-27
   PubMed Web of Science ®Google Scholar
• Nieuwenhuijs DJ, Olofsen E, Romberg RR, et al. Response surface modeling of remifentanil-propofol interaction on cardiorespiratory control and bispectral index. Anesthesiology 2003;98(2):312-22
   PubMed Web of Science ®Google Scholar
• Yassen A, Olofsen E, Romberg R, et al. Mechanism-based PK/PD modeling of the respiratory depressant effect of buprenorphine and fentanyl in healthy volunteers. Clin Pharmacol Ther 2007;81(1):50-8
   PubMed Web of Science ®Google Scholar
• Selley DE, Sim LJ, Xiao R, et al. mu-Opioid receptor-stimulated guanosine-5’-O-(gamma-thio)-triphosphate binding in rat thalamus and cultured cell lines: signal transduction mechanisms underlying agonist efficacy. Mol Pharmacol 1997;51(1):87-96
   PubMed Web of Science ®Google Scholar
• Boas RA, Villiger JW. Clinical actions of fentanyl and buprenorphine. The significance of receptor binding. Br J Anaesth 1985;57(2):192-6
   PubMed Web of Science ®Google Scholar
• Mildh LH, Scheinin H, Kirvela OA. The concentration-effect relationship of the respiratory depressant effects of alfentanil and fentanyl. Anesth Analg 2001;93(4):939-46
   PubMed Web of Science ®Google Scholar
• Bouillon T, Bruhn J, Radu-Radulescu L, et al. A model of the ventilatory depressant potency of remifentanil in the non-steady state. Anesthesiology 2003;99(4):779-87
   PubMed Web of Science ®Google Scholar
• Bouillon T, Schmidt C, Garstka G, et al. Pharmacokinetic-pharmacodynamic modeling of the respiratory depressant effect of alfentanil. Anesthesiology 1999;91(1):144-55
   PubMed Web of Science ®Google Scholar
• Nunn JF. Nunn’s applied respiratory physiology. Butterworth-Heineman; Oxford, Boston: 1993
   Google Scholar
• Olofsen E, Boom M, Nieuwenhuijs D, et al. Modeling the non-steady state respiratory effects of remifentanil in awake and propofol-sedated healthy volunteers. Anesthesiology 2010;112(6):1382-95
   PubMed Web of Science ®Google Scholar
• Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ 2006;174(11):1589-94
   PubMed Web of Science ®Google Scholar
• Iasnetsov VV, Drozd Iu V, Shashkov VS. Emetic and antiemetic properties of regulatory peptides. Biull Eksp Biol Med 1987;103(5):586-8
   PubMedGoogle Scholar
• Herndon CM, Jackson KC II, Hallin PA. Management of opioid-induced gastrointestinal effects in patients receiving palliative care. Pharmacotherapy 2002;22(2):240-50
   PubMed Web of Science ®Google Scholar
• Kurz A, Sessler DI. Opioid-induced bowel dysfunction: pathophysiology and potential new therapies. Drugs 2003;63(7):649-71
   PubMed Web of Science ®Google Scholar
• Shukla VK, Turndorf H, Bansinath M. Pertussis and cholera toxins modulate kappa-opioid receptor agonists-induced hypothermia and gut inhibition. Eur J Pharmacol 1995;292(3-4):293-9
   PubMed Web of Science ®Google Scholar
• Popper P, Cristobal R, Wackym PA. Expression and distribution of mu opioid receptors in the inner ear of the rat. Neuroscience 2004;129(1):225-33
   PubMed Web of Science ®Google Scholar
• Jongkamonwiwat N, Phansuwan-Pujito P, Sarapoke P, et al. The presence of opioid receptors in rat inner ear. Hear Res 2003;181(1-2):85-93
   PubMed Web of Science ®Google Scholar
• Xu XS, Etropolski M, Upmalis D, et al. Pharmacokinetic and pharmacodynamic modeling of opioid-induced gastrointestinal side effects in patients receiving tapentadol IR and oxycodone IR. Pharm Res 2012;29(9):2555-64
   PubMed Web of Science ®Google Scholar
• Olofsen E, Sigtermans M, Noppers I, et al. The dose-dependent effect of S(+)-ketamine on cardiac output in healthy volunteers and complex regional pain syndrome type 1 chronic pain patients. Anesth Analg 2012;115(3):536-46. doi: 10.1213/ANE.0b013e31825496f6. Epub 2012 May 10
   PubMed Web of Science ®Google Scholar
• Gavva NR. Body-temperature maintenance as the predominant function of the vanilloid receptor TRPV1. Trends Pharmacol Sci 2008;29(11):550-7
   PubMed Web of Science ®Google Scholar
• Honore P, Chandran P, Hernandez G, et al. Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermia. Pain 2009;142(1-2):27-35
   PubMed Web of Science ®Google Scholar
• Csajka C, Imbimbo BP, Piccinno A, et al. Mechanistic pharmacokinetic and pharmacodynamic modeling of CHF3381 (2-[(2,3-dihydro-1H-inden-2-yl)amino]acetamide monohydrochloride), a novel N-methyl-D-aspartate antagonist and monoamine oxidase-A inhibitor in healthy subjects. J Pharmacol Exp Ther 2005;313(2):647-57
   PubMed Web of Science ®Google Scholar
• Hawker GA, Mian S, Kendzerska T, French M. Measures of Adult Pain Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res 2011;63:S240-52
   PubMed Web of Science ®Google Scholar
• Kieschnick R, McCullough BD. Regression analysis of variates observed on (0, 1): percentages, proportions and fractions. Stat Model 2003;3:193-213
   Web of Science ®Google Scholar
• Ospina R, Ferrari SP. A general class of zero-or-one inflated beta regression models. Comput Stat Data Anal 2012;56(6):1609-23
   Web of Science ®Google Scholar
• Swearingen CJ, Melguizo Castro MS, Bursac Z. Modeling percentage outcomes: the %Beta_Regression Macro. SAS®Global Forum Proceedings Paper 2011;335:1-12
   Google Scholar
• Smithson M, Verkuilen J. A better lemon squeezer? Maximum-likelihood regression with beta-distributed dependent variables. Psychol Methods 2006;11(1):54-71
   PubMed Web of Science ®Google Scholar
• Cribari-Neto F, Zeileis A. Beta Regression in R. J Stat Software 2010;34(2):1-24
   Web of Science ®Google Scholar
• Ferrari SP, Cribari-Neto F. Beta regression for modelling rates and proportions. J Appl Stat 2004;31(7):799-815
   Web of Science ®Google Scholar
• Xu XS, Samtani MN, Dunne A, et al. Mixed-effects beta regression for modeling continuous bounded outcome scores using NONMEM when data are not on the boundaries. J Pharmacokinet Pharmacodyn 2013;40(4):537-44
   PubMed Web of Science ®Google Scholar
• Ospina R, Ferrari SP. Inflated beta distributions. Stat Paper 2010;51:111-26
   Web of Science ®Google Scholar
• Hu C, Yeilding N, Davis HM, Zhou H. Bounded outcome score modeling: application to treating psoriasis with ustekinumab. J Pharmacokinet Pharmacodyn 2011;38(4):497-517
   PubMed Web of Science ®Google Scholar
• Molas M, Lesaffre E. A comparison of three random effects approaches to analyze repeated bounded outcome scores with an application in a stroke revalidation study. Stat Med 2008;27(30):6612-33
   PubMed Web of Science ®Google Scholar
• FDA and EMA reach landmark decisions on C-Path’s simulation tool for Alzheimer’s disease. Critical Path Institute, Tuscon, Arizona. 2013. Available from: http://c-path.org/success/first-alzheimers-disease-progression-model-and-simulation-platform-in-review/ [Last accessed 7 November 2013]
   Google Scholar
• Xu XS, Wang H, Vermeulen A. Modeling delayed drug effect using discrete-time nonlinear autoregressive models: a connection with indirect response models. J Pharmacokinet Pharmacodyn 2011;38(3):353-67
   PubMed Web of Science ®Google Scholar
• Woodcock J, Witter J, Dionne RA. Stimulating the development of mechanism-based, individualized pain therapies. Nat Rev Drug Discov 2007;6(9):703-10
   PubMed Web of Science ®Google Scholar